About Aradigm Corporation
Focuses on the development and commercialization of drugs
At the moment the company generates 4M USD in revenues.
On its last earning announcement, the company reported a loss of -1.09$ per share.
The book value per share is -1.32$
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|